Long-term medical outcomes among aboriginal living kidney donors

Transplantation

Volumn 90, Issue 4, 2010, Pages 401-406

  Storsley, Leroy J ^a,b   Young, Ann ^c,d   Rush, David N ^a,b   Nickerson, Peter W ^a,b   Ho, Julie ^a,b   Suon, Vuthana ^b,e   Karpinski, Martin ^a,b  

^a UNIVERSITY OF MANITOBA   (Canada)

^b HEALTH SCIENCES CENTRE   (Canada)

^c UNIVERSITY OF WESTERN ONTARIO   (Canada)

^d LONDON HEALTH SCIENCES CENTRE   (Canada)

^e UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Aboriginal; Diabetes; Hypertension; Living kidney donor; Long term follow up

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ABORIGINE; ADULT; ANTIHYPERTENSIVE THERAPY; ARTICLE; CLINICAL ARTICLE; CONTROL GROUP; CONTROLLED STUDY; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HIGH RISK POPULATION; HUMAN; HYPERTENSION; KIDNEY DONOR; KIDNEY FAILURE; KIDNEY FUNCTION; LIVING DONOR; LONG TERM CARE; MALE; MEDICAL ASSESSMENT; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SYSTOLIC BLOOD PRESSURE;

BODY WEIGHT; CREATININE; FEMALE; FOLLOW-UP STUDIES; HUMANS; INDIANS, NORTH AMERICAN; KIDNEY TRANSPLANTATION; LIVING DONORS; MALE; MANITOBA; MIDDLE AGED; ONTARIO; PARENTS; PROTEINURIA; SIBLINGS; TREATMENT OUTCOME;

EID: 77955983111     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3181e6e79b     Document Type: Article

References (37)

1. BoudvilleN, Prasad GV, KnollG, et al; Donor Nephrectomy Outcomes Research (DONOR) Network. Meta-analysis: Risk for hypertension in living kidney donors. Ann Intern Med 2006; 145: 185.
2. Garg AX, Muirhead N, Knoll G, et al; Donor Nephrectomy Outcomes Research (DONOR) Network. Proteinuria and reduced kidney function in living kidney donors: A systematic review, meta-analysis and meta-regression. Kidney Int 2006; 70: 1801.
3. Ibrahim HN, Foley R, Tan L, et al. Long-term consequences of kidney donation. N Engl J Med 2009; 360: 459.
4. Ibrahim HN, Akkina SK, Leister E, et al. Pregnancy outcomes after kidney donation. Am J Transplant 2009; 9: 825.
5. Garg AX, Prasad GV, Thiessen-Philbrook HR, et al. Cardiovascular disease and hypertension risk in living kidney donors: An analysis of health administrative data in Ontario, Canada. Transplantation 2008; 86: 399.
6. Fehrman-Ekholm I, Elinder CG, Stenbeck M, et al. Kidney donors live longer. Transplantation 1997; 64: 976.
7. Goldfarb DA, Matin SF, Braun WE, et al. Renal outcome 25 years after donor nephrectomy. J Urol 2001; 166: 2043.
8. Fournier C, Kreis H, Pucheu S, et al. Very long-term data on living kidney donors: A single center experience since 1959. Am J Transplant 2009; 9(suppl 2): S342; ATC Abstract #527.
9. Tarver-Carr ME, Powe NR, Eberhardt MS, et al. Excess risk of chronic kidney disease among African-American versus white subjects in the United States: A population-based study of potential explanatory factors. J Am Soc Nephrol 2002; 13: 2363.
10. MacMillan HL, Walsh CA, Jamieson E, et al; Technical Advisory Committee of the Chiefs of Ontario. The health of Ontario First Nations people: Results from the Ontario First Nations Regional Health Survey. Can J Public Health 2003; 94: 168.
11. Green C, Blanchard JF, Young TK, et al. The epidemiology of diabetes in the Manitoba registered First Nations population: Current patterns and comparative trends. Diabetes Care 2003; 26: 1993.
12. Young TK, Reading J, Elias B, et al. Type 2 diabetes in Canada's First Nations: Status of an epidemic in progress. CMAJ 2000; 163: 561.
13. Young BA, Maynard C, Boyko EJ. Racial differences in diabetic ne-phropathy, cardiovascular disease and mortality in a national population of veterans. Diabetes Care 2003; 26: 2393.
14. Gao S, Manns BJ, Culleton BF, et al; Alberta Kidney Disease Network. Prevalence of chronic kidney disease and survival among Aboriginal people. J Am Soc Nephrol 2007; 18: 2053.
15. Scavini M, Stidley CA, Paine SS, et al. The burden of chronic kidney disease among the Zuni Indians: The Zuni Kidney Project. Clin J Am Soc Nephrol 2007; 2: 509.
16. Hochman ME, Watt JP, Reid R, et al. The prevalence and incidence of end-stage renal disease in Native American adults on the Navajo reservation. Kidney Int 2007; 71: 931.
17. McDonald SP, Russ GR. Current incidence, treatment patterns and outcomes of end-stage renal disease among indigenous groups on Australia and New Zealand. Nephrology 2003; 8: 42.
18. Anand SS, Yusuf S, Jacobs R, et al. Risk factors, atherosclerosis, and cardiovascular disease among Aboriginal people in Canada: The Study of Health Assessment and Risk Evaluation in Aboriginal Peoples (SHARE-AP). Lancet 2001; 358: 1147.
19. Welty TK, Rhoades DA, Yeh F, et al. Changes in cardiovascular disease risk factors among American Indians. The Strong Heart Study. Ann Epidemiol 2002; 12: 97.
20. First Nations and Inuit Regional Health Survey. First Nations and Inuit Regional Health Survey National Steering Committee, January 1999. Available at: http://rhs-ers.ca/english/pdf/rhs1997/rhs-1997-final- report.pdf. Accessed November 2009.
21. Wang Z, Knight S, Wilson A, et al. Blood pressure and hypertension for Australian Aboriginal and Torres Strait Islander people. Eur J Cardio-vasc Prev Rehabil 2006; 13: 438.
22. Rogers NM, Lawton PD, Jose MD. Indigenous Australians and living kidney donation. N Engl J Med 2009; 361: 1513.
23. Statistics Canada. 2006 Aboriginal population profile. Available at: http://www.statcan.gc.ca. Accessed November 2009.
24. Manitoba Aboriginal and Northern Affairs. Aboriginal people in Manitoba 2000. Available at: http://www.gov.mb.ca/ana/apm2000/1/k.html. Accessed November 2009.
25. Levey AS, Bosch JP, Lewis JB, et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999; 130: 461.
26. Newcombe RG. Two-sided confidence intervals for the single proportion: Comparison of seven methods. Stat Med 1998; 17: 857.
27. Vittinghoff E, Glidden DV, Shiboski SC, et al. Regression Methods in Biostatistics: Linear, Logistic, Survival and Repeated Measures Models. New York, USA: Springer Science+Business Media Inc. 2005.
28. Young A, Storsley L, Garg AX, et al. Health outcomes for living kidney donors with isolated medical abnormalities: A systematic review. Am J Transplant 2008; 8: 1878.
29. Mandelbrot DA, Pavlakis M, Danovitch GM, et al. The medical evaluation of living kidney donors: A survey of US transplant centers. Am J Transplant 2007; 7: 2333.
30. Reese PP, Feldman HI, McBride MA, et al. Substantial variation in the acceptance of medically complex live kidney donors across US renal transplant centers. Am J Transplant 2008; 8: 2062.
31. Organ Procurement and Transplantation Network (OPTN), US Department of Health and Human Services. Available at: http://optn. transplant.hrsa.gov. Accessed November 2009.
32. Bulloch B, Postl BD, Ogborn MR. Excess prevalence of non-diabetic renal disease in native American children in Manitoba. Pediatr Nephrol 1996; 10: 702.
33. Australian Institute of Health and Welfare. The Health and Welfare of Australia's Aboriginal and Torres Strait Islander Peoples 2001. Available at: http://www.aihw.gov.au/publications/ihw/hwaatsip01/. Accessed November 2009.
34. Seaquist ER, Goetz FC, Rich S, et al. Familial clustering of diabetic kidney disease. Evidence for genetic susceptibility to diabetic nephropathy. N Engl J Med 1989; 320: 1161.
35. Levey AS, Stevens LA, Schmid CH, et al; CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration). A new equation to estimate glomerular filtration rate. Ann Intern Med 2009; 150: 604.
36. Young A, Karpinski M, Treleaven D, et al. Differences in tolerance for health risk to the living donor among potential donors, recipients, and transplant professionals. Kidney Int 2008; 73: 1159.
37. Steiner RW. Risk appreciation for living kidney donors: Another new subspecialty? Am J Transplant 2004; 4: 694.